Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)

项目总结 VECDor全球健康培训计划(GHTP)由四个杰出的机构组成-范德比尔特(V)， Emory(E)、Cornell(C)和Duke(D)--统称为VECD--与VCD建立了数十年的全球合作伙伴关系 非洲顶级LMIC研究机构(肯尼亚、赞比亚、坦桑尼亚、莫桑比克、埃塞俄比亚、加纳、 尼日利亚、卢旺达)、亚洲(印度、越南)、拉丁美洲(洪都拉斯、尼加拉瓜、危地马拉)和 加勒比海(海地)。总体而言，VECDor资金雄厚的研究组合包括各种和 传染病和非传染性疾病(非传染性疾病)的补充专题。所有VECDor机构都有 在全球卫生培训方面进行了大量投资，这将继续最大限度地利用 美国国立卫生研究院资源公司。VECDor机构和教职员工在全球参与、调查 成就和卓越的指导，通过成功部署和指导87名VECDor来证明 2012-2017年的高效实习生。使用高效的支持中心，最大限度地提高 资金用于研究培训，并利用多种财政和实物联合资金来源，我们将联系 与T32和其他NIH资助的培训计划以及少数族裔机构合作伙伴一起选择和 从2017年到2022年，部署80到100名美国和LMIC实习生，他们在研究职业生涯中有着突出的前景。 VECDor将在整个财团实施战略指导和学员支持计划，包括 在实地部署之前和研究年后继续进行的实质性准备阶段是 完成，以确保最高质量的研究出版物和科学会议演示文稿以及 使学员在获得研究和职业发展资助方面取得最大成功。研究主题将 讲解学员和美国国立卫生研究院研究所和中心感兴趣的所有主题和地理领域。我们会 通过长期监测和评估(M&E)计划记录该计划的影响，该计划跟踪 所有受训者的职业方向和产出，并将进一步完善我们现有的基于网络的工具，以分享 知识，促进本地和全球网络，并加强和保持临床研究技能 全球健康研究员和校友。VECDor建立在我们美国和全球合作伙伴以及我们的 研究、创新和指导的集体记录。结合我们最近在以下领域的丰富经验 研究培训计划管理，全球重大疾病研究资金基础雄厚 重要意义、著名的国际研究培训伙伴和地点，以及加强机构共同资助 承诺，VECDor将继续培养21世纪全球卫生研究队伍的关键成员 世纪，就像我们在现任VECDor计划内所做的那样。

PROJECT SUMMARY The VECDor Global Health Training Program (GHTP) comprises four outstanding institutions – Vanderbilt (V), Emory (E), Cornell (C), and Duke (D) – collectively, VECD – with decades-long global partnerships with premier LMIC research institutions in Africa (Kenya, Zambia, Tanzania, Mozambique, Ethiopia, Ghana, Nigeria, Rwanda), Asia (India, Vietnam), Latin America (Honduras, Nicaragua, Guatemala), and the Caribbean (Haiti). Collectively, VECDor's well-funded research portfolio encompasses diverse and complementary topics in communicable and non-communicable diseases (NCDs). All VECDor institutions have made substantial investments in global health training, which will continue to provide maximal leveraging of NIH resources. VECDor institutions and faculty have a long history of global engagement, investigative accomplishment, and mentoring excellence, evidenced by successfully deploying and mentoring 87 VECDor highly productive trainees from 2012-2017. Using a highly efficient support center that maximizes the direction of funds to research training, and leveraging multiple sources of financial and in-kind co-funding, we will link with T32 and other NIH-funded training programs and with minority institution partners to select and deploy 80 to 100 US and LMIC trainees from 2017-2022 with outstanding promise for research careers. VECDor will implement a strategic mentoring and trainee support plan across the consortium, including a substantial preparation phase prior to field deployment and continuing after the research year is completed, to ensure the highest quality research publications and scientific meeting presentations and maximum trainee success in obtaining research and career development grants. Research themes will address all topic and geographical areas of interest to trainees and NIH Institutes and Centers. We will document the Program's impact through a long-term monitoring and evaluation (M&E) plan that tracks the career directions and outputs of all trainees and will further refine our existing web-based tools to share knowledge, foster local and global networking, and strengthen and sustain clinical research skills among global health fellows and alumni. VECDor is built on the mutual respect of our US and global partners and our collective track record of research innovation and mentorship. Combining our extensive recent experience in research training program management, robust research funding bases in major diseases of global significance, renowned international research training partners and sites, and enhanced institutional co-funding commitments, VECDor will continue to nurture key members of the global health research workforce of the 21st century, as we have done within the incumbent VECDor program.